Antibiotics, microbiota, and immune defense

Trends in Immunology

Volumn 33, Issue 9, 2012, Pages 459-466

  Ubeda, Carles ^a   Pamer, Eric G ^b,c  

^a Center for Advanced Research in Public Health   (Spain)

^b Memorial Hospital   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Allergy; Antibiotics; Immunity; Infection; Microbiota

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFALEXIN; CEFOPERAZONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; GENTAMICIN; INFLAMMASOME; KANAMYCIN; METRONIDAZOLE; NEOMYCIN; QUINOLONE DERIVATIVE; STREPTOMYCIN; VANCOMYCIN;

ANTIBODY RESPONSE; COMMENSAL; FECES MICROFLORA; HUMAN; IMMUNE SYSTEM; IMMUNITY; INTESTINE; INTESTINE FLORA; LYMPHOID CELL; MICROBIAL COMMUNITY; NONHUMAN; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; METAGENOME;

EID: 84865286121     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.05.003     Document Type: Review

References (80)

1. Hooper L.V., et al. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 2002, 22:283-307.
2. Vollaard E.J., Clasener H.A. Colonization resistance. Antimicrob. Agents Chemother. 1994, 38:409-414.
3. Hill D.A., Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu. Rev. Immunol. 2010, 28:623-667.
4. Brandl K., et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008, 455:804-807.
5. Hill D.A., et al. Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat. Med. 2012, 18:538-546.
6. Abraham C., Cho J.H. Inflammatory bowel disease. N. Engl. J. Med. 2009, 361:2066-2078.
7. Wen L., et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 2008, 455:1109-1113.
8. Wu H.-J., et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
9. Eckburg P.B. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
10. Garner C.D., et al. Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar Typhimurium murine model of infection. Infect. Immun. 2009, 77:2691-2702.
11. Ubeda C., et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 2010, 120:4332-4341.
12. Hill D.A., et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 2009, 3:148-158.
13. Cash H.L. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313:1126-1130.
14. Brandl K., et al. MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J. Exp. Med. 2007, 204:1891-1900.
15. Vaishnava S., et al. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20858-20863.
16. Sonnenburg J.L., et al. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol. 2006, 4:e413.
17. Vaishnava S., et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011, 334:255-258.
18. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8:411-420.
19. Kobayashi K.S., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307:731-734.
20. Bouskra D., et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008, 456:507-510.
21. Clarke T.B., et al. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 2010, 16:228-231.
22. Brenchley J.M., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12:1365-1371.
23. Shi C., et al. Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 2011, 34:590-601.
24. Strowig T., et al. Inflammasomes in health and disease. Nature 2012, 481:278-286.
25. Kofoed E.M., Vance R.E. Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 2011, 477:592-595.
26. Elinav E., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
27. Henao-Mejia J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
28. Sanos S.L., et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 2009, 10:83-91.
29. Luci C., et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 2009, 10:75-82.
30. Satoh-Takayama N., et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008, 29:958-970.
31. Bird L. Host response: antimicrobial function for IL-22. Nat. Rev. Microbiol. 2008, 6:259.
32. Lee J.S., et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 2011, 13:144-151.
33. Qiu J., et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2012, 36:92-104.
34. Kiss E.A., et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011, 334:1561-1565.
35. Perdew G.H., Babbs C.F. Production of Ah receptor ligands in rat fecal suspensions containing tryptophan or indole-3-carbinol. Nutr. cancer 1991, 16:209-218.
36. Ismail A.S., et al. Gammadelta intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:8743-8748.
37. Li Y., et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 2011, 147:629-640.
38. Mazmanian S., et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
39. Mitsdoerffer M., et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14292-14297.
40. Tesmer L.A., et al. Th17 cells in human disease. Immunol. Rev. 2008, 223:87-113.
41. Atarashi K., et al. ATP drives lamina propria TH17 cell differentiation. Nature 2008, 455:808-812.
42. Ivanov I.I., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
43. Ivanov I.I., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
44. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12204-12209.
45. Atarashi K., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
46. Lathrop S.K., et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011, 478:250-254.
47. Hapfelmeier S., et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010, 328:1705-1709.
48. Dethlefsen L., et al. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008, 6:e280.
49. Jernberg C., et al. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007, 1:56-66.
50. Antonopoulos D.A., et al. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect. Immun. 2009, 77:2367-2375.
51. Buffie C.G., et al. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect. Immun. 2012, 80:62-73.
52. Sekirov I., et al. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 2008, 76:4726-4736.
53. Tanaka S., et al. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol. Med. Microbiol. 2009, 56:80-87.
54. Schumann A. Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome. Physiol. Genomics 2005, 23:235-245.
55. Wlodarska M., et al. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 2011, 79:1536-1545.
56. Dufour V., et al. Effects of a short-course of amoxicillin/clavulanic acid on systemic and mucosal immunity in healthy adult humans. Int. Immunopharmacol. 2005, 5:917-928.
57. Hill D.A., et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 2010, 3:148-158.
58. Endt K., et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog. 2010, 6:e1001097.
59. Miller C., Bohnhoff M. Changes in the mouse's enteric microflora associated with enhanced susceptibility to Salmonella infection following streptomycin treatment. J. Infect. Dis. 1963, 113:59-66.
60. Bohnhoff M., Miller C. Resistance of the mouse's intestinal tract to experimental Salmonella infection. J. Exp. Med. 1964, 120:805-816.
61. Rupnik M., et al. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 2009, 7:526-536.
62. Chang J.Y., et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J. Infect. Dis. 2008, 197:435-438.
63. Lawley T.D., et al. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect. Immun. 2009, 77:3661-3669.
64. Hasegawa M., et al. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J. Immunol. 2011, 186:4872-4880.
65. Ichinohe T., et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:5354-5359.
66. Kane M., et al. Successful transmission of a retrovirus depends on the commensal microbiota. Science 2011, 334:245-249.
67. Eder W., et al. The asthma epidemic. N. Engl. J. Med. 2006, 355:2226-2235.
68. Strachan D.P. Hay fever, hygiene, and household size. BMJ 1989, 299:1259-1260.
69. Chen Y., Blaser M.J. Helicobacter pylori colonization is inversely associated with childhood asthma. J. Infect. Dis. 2008, 198:553-560.
70. Watanabe J., et al. Administration of antibiotics during infancy promoted the development of atopic dermatitis-like skin lesions in NC/Nga mice. Biosci. Biotechnol. Biochem. 2010, 74:358-363.
71. Bashir M.E.H., et al. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol. 2004, 172:6978-6987.
72. Russell S.L., et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012, 13:440-447.
73. Cover T.L., Blaser M.J. Helicobacter pylori in health and disease. Gastroenterology 2009, 136:1863-1873.
74. Islami F., Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev. Res. (Phila) 2008, 1:329-338.
75. Wolvers D., et al. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J. Nutr. 2010, 140:698S-712S.
76. Hickson M., et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007, 335:80.
77. Hall J.A., et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008, 29:637-649.
78. Kinnebrew M.A., et al. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J. Infect. Dis. 2010, 201:534-543.
79. Kinnebrew M.A., et al. Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 2012, 36:276-287.
80. Jarchum I., et al. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect. Immun. 2011, 79:1498-1503.